Page 374 - Binder2

Implications: The Three Disintermediated Pillars

The edible biologics revolution isn’t just about new
molecules or new delivery formats. It’s about the
dismantling of old gatekeeping systems—institutions and
roles that have long defined how medicine moves from lab
to life.

Three pillars of the current biologics delivery model—
doctors, clinics, and pharmacies—have historically
controlled access to these therapies. But with the rise of
shelf-stable, orally administered, AI-guided, plant-
grown biologics, their roles are being radically redefined.

This isn’t about erasing these institutions. It’s about
liberating them from a model optimized for complexity,
procedure, and scarcity.

Let’s take a closer look.

1. Doctors: From Gatekeepers to Guides

In today’s system, biologic drugs are largely managed by
medical specialists. Rheumatologists, gastroenterologists,
dermatologists—they are trained to initiate, monitor, and
escalate therapy as needed. They interpret labs, watch for
immune rejection, and coordinate infusion schedules. These
roles are critical, especially when biologics are risky,
unstable, or highly individualized.

But plant-based, orally delivered biologics disrupt the
clinical calculus:

372